Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease

[1]  R. Kukreti,et al.  Oxidative Stress: A Key Modulator in Neurodegenerative Diseases , 2019, Molecules.

[2]  Anne Richelle,et al.  Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0 , 2019, Nature Protocols.

[3]  H. U. Zacharias,et al.  Dilution correction for dynamically influenced urinary analyte data. , 2018, Analytica chimica acta.

[4]  Nandkishor K. Mule,et al.  Diabetes Mellitus to Neurodegenerative Disorders: Is Oxidative Stress Fueling the Flame? , 2018, CNS & neurological disorders drug targets.

[5]  Jinyi Li,et al.  Bioinformatic analysis for the identification of key candidate genes and pathways in the substantia nigra in Parkinson's disease. , 2018, Journal of integrative neuroscience.

[6]  Ren Yan,et al.  Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels , 2018, Front. Microbiol..

[7]  H. Sokol,et al.  Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice , 2018, Nature Communications.

[8]  Eugen Bauer,et al.  From metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn’s disease , 2018, npj Systems Biology and Applications.

[9]  P. Brundin,et al.  Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles. , 2018, Journal of proteome research.

[10]  Piotr Gawron,et al.  The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease , 2018, bioRxiv.

[11]  Federico Baldini,et al.  The Microbiome Modeling Toolbox: from microbial interactions to personalized microbial communities , 2018, bioRxiv.

[12]  S. Mantri,et al.  Physical Activity in Early Parkinson Disease , 2018, Journal of Parkinson's disease.

[13]  Avlant Nilsson,et al.  Recon3D: A Resource Enabling A Three-Dimensional View of Gene Variation in Human Metabolism , 2018, Nature Biotechnology.

[14]  Ronan M. T. Fleming,et al.  Personalized modeling of the human gut microbiome reveals distinct bile acid deconjugation and biotransformation potential in healthy and IBD individuals , 2017, bioRxiv.

[15]  N. Friedrich,et al.  Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals , 2017, BMC Medicine.

[16]  J. Dodge.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases , 2017, Front. Mol. Neurosci..

[17]  A. Heintz‐Buschart,et al.  The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.

[18]  J. Havelund,et al.  Biomarker Research in Parkinson’s Disease Using Metabolite Profiling , 2017, Metabolites.

[19]  Anne-Marie Wills,et al.  Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort , 2017, Journal of Neurology.

[20]  Luis Pedro Coelho,et al.  Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients , 2017, Genome Medicine.

[21]  A. Bender,et al.  Concordance analysis of microarray studies identifies representative gene expression changes in Parkinson’s disease: a comparison of 33 human and animal studies , 2017, BMC Neurology.

[22]  E. Allen-Vercoe,et al.  Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice , 2017, Scientific Reports.

[23]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[24]  Ronan M. T. Fleming,et al.  Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota , 2016, Nature Biotechnology.

[25]  G. Gerhard,et al.  Bile Acids in Neurodegenerative Disorders , 2016, Front. Aging Neurosci..

[26]  P. Wilmes,et al.  A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility , 2016, Cell.

[27]  Y. Loh,et al.  Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis. , 2016, JAMA neurology.

[28]  T. Friede,et al.  Monitoring of 30 marker candidates in early Parkinson disease as progression markers , 2016, Neurology.

[29]  Henry C. Lin,et al.  Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract , 2015, Microorganisms.

[30]  A. Lang,et al.  Parkinson's disease , 2015, The Lancet.

[31]  Nikolaus R. McFarland,et al.  Weight Loss and Impact on Quality of Life in Parkinson’s Disease , 2015, PloS one.

[32]  E. Pekkonen,et al.  Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.

[33]  Gabriela Kalna,et al.  A Study of the Effects of Exercise on the Urinary Metabolome Using Normalisation to Individual Metabolic Output , 2015, Metabolites.

[34]  Marilena Aiello,et al.  Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms , 2015, Appetite.

[35]  I. Vattulainen,et al.  Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes? , 2014, Chemistry and physics of lipids.

[36]  Corey D. DeHaven,et al.  High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High- Throughput Profiling Metabolomics , 2014 .

[37]  G. Leipnitz,et al.  Sulfite disrupts brain mitochondrial energy homeostasis and induces mitochondrial permeability transition pore opening via thiol group modification. , 2014, Biochimica et biophysica acta.

[38]  F. Jiménez-Jiménez,et al.  COMT gene and risk for Parkinson’s disease: a systematic review and meta-analysis , 2014, Pharmacogenetics and genomics.

[39]  Hongzhu Li,et al.  Regulation of cystathionine gamma-lyase/H₂S system and its pathological implication. , 2014, Frontiers in bioscience.

[40]  H. Liany,et al.  A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease , 2013, Neurobiology of Aging.

[41]  J. Slotte,et al.  Biological functions of sphingomyelins. , 2013, Progress in lipid research.

[42]  T. Friede,et al.  Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort , 2013, Neurology.

[43]  H. Kitano,et al.  Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map , 2013, Molecular Neurobiology.

[44]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[45]  M. Nalls,et al.  The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  Beate Ritz,et al.  α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease , 2012, PloS one.

[47]  Rui Wang.  Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. , 2012, Physiological reviews.

[48]  Yunwei Wang,et al.  Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice , 2012, Nature.

[49]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[50]  Y. Benjamini.  Discovering the false discovery rate , 2010 .

[51]  Eytan Ruppin,et al.  Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model , 2010, Bioinform..

[52]  J. Bian,et al.  Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models , 2010, Aging cell.

[53]  Ronan M. T. Fleming,et al.  Reconstruction and Use of Microbial Metabolic Networks: the Core Escherichia coli Metabolic Model as an Educational Guide. , 2010, EcoSal Plus.

[54]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[55]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[56]  Y. Alnouti.  Bile Acid sulfation: a pathway of bile acid elimination and detoxification. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[57]  J. Jankovic,et al.  A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics , 2008, Movement disorders : official journal of the Movement Disorder Society.

[58]  J. Bełtowski,et al.  Adiponectin and its role in cardiovascular diseases. , 2008, Cardiovascular & hematological disorders drug targets.

[59]  V. Ravindranath,et al.  Inhibition of cystathionine-γ-lyase leads to loss of glutathione and aggravation of mitochondrial dysfunction mediated by excitatory amino acid in the CNS , 2007, Neurochemistry International.

[60]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.

[61]  J. D. Engel,et al.  Genetic Evidence that Small Maf Proteins Are Essential for the Activation of Antioxidant Response Element-Dependent Genes , 2005, Molecular and Cellular Biology.

[62]  B. Halliwell,et al.  A Mechanism of Sulfite Neurotoxicity , 2004, Journal of Biological Chemistry.

[63]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[64]  D. Woitalla,et al.  3-OMD and homocysteine plasma levels in parkinsonian patients , 2002, Journal of Neural Transmission.

[65]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[66]  B. Halliwell,et al.  The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson's disease. , 1999, Free radical biology & medicine.

[67]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[68]  Leslie E. Papke,et al.  Econometric Methods for Fractional Response Variables with an Application to 401(K) Plan Participation Rates , 1993 .

[69]  R. Kronmal.  Spurious Correlation and the Fallacy of the Ratio Standard Revisited , 1993 .

[70]  A. Wolkoff,et al.  Transport of chenodeoxycholic acid and its 3‐α‐ and 7‐α‐sulfates by isolated perfused rat liver , 1990 .

[71]  Ines Thiele,et al.  Computational Modeling of Human Metabolism and Its Application to Systems Biomedicine. , 2016, Methods in molecular biology.

[72]  C. Mantzoros,et al.  From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. , 2015, Metabolism: clinical and experimental.

[73]  J. Finley,et al.  The USDA-Agricultural Research Service (ARS) Program in Dietary Surveillance and Food Composition: State of the Program and Future Directions , 2013 .

[74]  G. Schmitz,et al.  Metabolism and atherogenic disease association of lysophosphatidylcholine. , 2010, Atherosclerosis.

[75]  Ling-Ling Yang,et al.  Mechanism of neuroprotective function of taurine. , 2009, Advances in experimental medicine and biology.

[76]  S. Oja,et al.  Taurine release in mouse brain stem slices under cell-damaging conditions , 2006, Amino Acids.